Harmonization of Glutamic Acid Decarboxylase and Islet Antigen-2 Autoantibody Assays for National Institute of Diabetes and Digestive and Kidney Diseases Consortia
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND/RATIONALE: Autoantibodies to islet antigen-2 (IA-2A) and glutamic acid decarboxylase (GADA) are markers for diagnosis, screening, and measuring outcomes in National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) consortia studies. A harmonization program was established to increase comparability of results within and among these studies. METHODS: Large volumes of six working calibrators were prepared from pooled sera with GADA 4.8-493 World Health Organization (WHO) units/ml and IA-2A 2-235 WHO units/ml. Harmonized assay protocols for IA-2A and GADA using (35)S-methionine-labelled in vitro transcribed and translated antigens were developed based on methods in use in three NIDDK laboratories. Antibody thresholds were defined using sera from patients with recent onset type 1 diabetes and healthy controls. To evaluate the impact of the harmonized assay protocol on concordance of IA-2A and GADA results, two laboratories retested stored TEDDY study sera using the harmonized assays. RESULTS: The harmonized assays gave comparable but not identical results in the three laboratories. For IA-2A, using a common threshold of 5 DK units/ml, 549 of 550 control and patient samples were concordantly scored as positive or negative, specificity was greater than 99% with sensitivity 64% in all laboratories. For GADA, using thresholds equivalent to the 97th percentile of 974 control samples in each laboratory, 1051 (97.9%) of 1074 samples were concordant. On the retested TEDDY samples, discordance decreased from 4 to 1.8% for IA-2A (n = 604 samples; P = 0.02) and from 15.4 to 2.7% for GADA (n = 515 samples; P < 0.0001). CONCLUSION: Harmonization of GADA and IA-2A is feasible using large volume working calibrators and common protocols and is an effective approach to ensure consistency in autoantibody measurements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An international harmonized protocol for measurement of IA‐2A has also been established [ 6 ]”
From Islet autoantibody profiles associated with higher diabetes risk in Lithuanian compared with English schoolchildren (2020) · cites this paper as [6]
In the citing paper
“The performance of GADA and IA-2A assays is improving, as demonstrated by the Islet Autoantibody Standardization Program (440,442).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [440]
In the citing paper
“Data from the Diabetes Autoantibody Standardization Program (DASP) (439) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop (440) demonstrate that the interlaboratory variability for IAA is inappropriately large.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [440]
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s055 · Cited by 1,062
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Self-citationZiegler, A. G., Hummel, M., Schenker, M., & Bonifacio, E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 645
Self-citationDiabetes Antibody Standardization Program: first assay proficiency evaluation
Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362
Self-citationThe Environmental Determinants of Diabetes in the Young (TEDDY) Study
TEDDY Study Group (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.062 · Cited by 306
Törn, C., Mueller, P. W., Schlosser, M., Bonifacio, E., Bingley, P. J., & Laboratories, P. (2008) · Diabetologia · doi:10.1007/s00125-008-0967-2 · Cited by 284
Self-citation(2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.08.002 · Cited by 268
The TODAY Study Group (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00237.x · Cited by 260
Hagopian, W. A., Erlich, H., Lernmark, Å., Rewers, M., Ziegler, A. G., Simell, O., Akolkar, B., Vogt, R., Blair, A., Ilonen, J., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00774.x · Cited by 260
Self-citation
Cited by
Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012
Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610187 · Cited by 1,476
Self-citationKatsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.16 · Cited by 1,475
Self-citationPrevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., Divers, J., Bell, R., Badaru, A., Talton, J. W., Crume, T., et al. (2014) · JAMA · doi:10.1001/jama.2014.3201 · Cited by 1,412
Dabelea, D., Stafford, J. M., Mayer-Davis, E. J., D’Agostino, R., Dolan, L., Imperatore, G., Linder, B., Lawrence, J. M., Marcovina, S. M., Mottl, A. K., et al. (2017) · JAMA · doi:10.1001/jama.2017.0686 · Cited by 700
Self-citationTrends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017
Lawrence, J. M., Divers, J., Isom, S., Saydah, S., Imperatore, G., Pihoker, C., Marcovina, S. M., Mayer-Davis, E. J., Hamman, R. F., Dolan, L., et al. (2021) · JAMA · doi:10.1001/jama.2021.11165 · Cited by 619
Self-citationthe TEDDY Study Group, Krischer, J. P., Lynch, K. F., Schatz, D. A., Ilonen, J., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Simell, O. G., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3514-y · Cited by 444
Self-citationPihoker, C., Gilliam, L. K., Ellard, S., Dabelea, D., Davis, C., Dolan, L. M., Greenbaum, C. J., Imperatore, G., Lawrence, J. M., Marcovina, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1279 · Cited by 397
Self-citationSacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany
Ziegler, A.-G., Kick, K., Bonifacio, E., Haupt, F., Hippich, M., Dunstheimer, D., Lang, M., Laub, O., Warncke, K., Lange, K., et al. (2020) · JAMA · doi:10.1001/jama.2019.21565 · Cited by 312
Self-citationAssociation of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study
Uusitalo, U., Liu, X., Yang, J., Aronsson, C. A., Hummel, S., Butterworth, M., Lernmark, Å., Rewers, M., Hagopian, W., She, J.-X., et al. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.2757 · Cited by 292
Self-citationRheumatoid Arthritis Pathogenesis, Prediction, and Prevention: An Emerging Paradigm Shift
Deane, K. D., & Holers, V. M. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41417 · Cited by 255
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
Arif, S., Leete, P., Nguyen, V., Marks, K., Nor, N. M., Estorninho, M., Kronenberg-Versteeg, D., Bingley, P. J., Todd, J. A., Guy, C., et al. (2014) · Diabetes · doi:10.2337/db14-0365 · Cited by 238
Self-citationCampbell‐Thompson, M., Wasserfall, C., Kaddis, J., Albanese‐O'Neill, A., Staeva, T., Nierras, C., Moraski, J., Rowe, P., Gianani, R., Eisenbarth, G., et al. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2316 · Cited by 236
Self-citationProspective virome analyses in young children at increased genetic risk for type 1 diabetes
the TEDDY Study Group, Vehik, K., Lynch, K. F., Wong, M. C., Tian, X., Ross, M. C., Gibbs, R. A., Ajami, N. J., Petrosino, J. F., Rewers, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0667-0 · Cited by 235
Self-citationHummel, S., Pflüger, M., Hummel, M., Bonifacio, E., & Ziegler, A.-G. (2011) · Diabetes Care · doi:10.2337/dc10-2456 · Cited by 218
Self-citationFasolino, M., Schwartz, G. W., Patil, A. R., Mongia, A., Golson, M. L., Wang, Y. J., Morgan, A., Liu, C., Schug, J., Liu, J., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00531-x · Cited by 210
Bonifacio, E., Ziegler, A.-G., Klingensmith, G., Schober, E., Bingley, P. J., Rottenkolber, M., Theil, A., Eugster, A., Puff, R., Peplow, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.2928 · Cited by 196
Self-citationSteck, A. K., Vehik, K., Bonifacio, E., Lernmark, A., Ziegler, A.-G., Hagopian, W. A., She, J., Simell, O., Akolkar, B., Krischer, J., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2426 · Cited by 185
Self-citationKrischer, J. P., Lynch, K. F., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Toppari, J., Ziegler, A.-G., Akolkar, B., & the TEDDY Study Group (2017) · Diabetes Care · doi:10.2337/dc17-0238 · Cited by 185
Self-citationEtiological Approach to Characterization of Diabetes Type
Dabelea, D., Pihoker, C., Talton, J. W., D’Agostino, R. B., Fujimoto, W., Klingensmith, G. J., Lawrence, J. M., Linder, B., Marcovina, S. M., Mayer-Davis, E. J., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2324 · Cited by 183
Self-citationAutoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report
Hollstein, T., Schulte, D. M., Schulz, J., Glück, A., Ziegler, A. G., Bonifacio, E., Wendorff, M., Franke, A., Schreiber, S., Bornstein, S. R., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00281-8 · Cited by 176
Self-citationon behalf of the TEDDY Study Group, Lönnrot, M., Lynch, K. F., Elding Larsson, H., Lernmark, Å., Rewers, M. J., Törn, C., Burkhardt, B. R., Briese, T., Hagopian, W. A., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4365-5 · Cited by 171
Self-citationImmunogenetics of type 1 diabetes mellitus
Morran, M. P., Vonberg, A., Khadra, A., & Pietropaolo, M. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.004 · Cited by 166
Follicular helper T cell signature in type 1 diabetes
Kenefeck, R., Wang, C. J., Kapadi, T., Wardzinski, L., Attridge, K., Clough, L. E., Heuts, F., Kogimtzis, A., Patel, S., Rosenthal, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76238 · Cited by 165
Pancreatic Volume Is Reduced in Adult Patients with Recently Diagnosed Type 1 Diabetes
Williams, A. J. K., Thrower, S. L., Sequeiros, I. M., Ward, A., Bickerton, A. S., Triay, J. M., Callaway, M. P., & Dayan, C. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1815 · Cited by 165
Self-citationSacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 206
Role of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study
Törn, C., Hadley, D., Lee, H.-S., Hagopian, W., Lernmark, Å., Simell, O., Rewers, M., Ziegler, A., Schatz, D., Akolkar, B., et al. (2015) · Diabetes · doi:10.2337/db14-1497 · Cited by 151
Self-citationBonifacio, E., Beyerlein, A., Hippich, M., Winkler, C., Vehik, K., Weedon, M. N., Laimighofer, M., Hattersley, A. T., Krumsiek, J., Frohnert, B. I., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002548 · Cited by 148
Self-citationA combined risk score enhances prediction of type 1 diabetes among susceptible children
Ferrat, L. A., Vehik, K., Sharp, S. A., Lernmark, Å., Rewers, M. J., She, J.-X., Ziegler, A.-G., Toppari, J., Akolkar, B., Krischer, J. P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0930-4 · Cited by 148
Self-citationDabelea, D., D’Agostino, R. B., Mason, C. C., West, N., Hamman, R. F., Mayer-Davis, E. J., Maahs, D., Klingensmith, G., Knowler, W. C., & Nadeau, K. (2011) · Diabetologia · doi:10.1007/s00125-010-1911-9 · Cited by 146
Raab, J., Haupt, F., Scholz, M., Matzke, C., Warncke, K., Lange, K., Assfalg, R., Weininger, K., Wittich, S., Löbner, S., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011144 · Cited by 144
Self-citationCost and cost-effectiveness of large-scale screening for type 1 diabetes in Colorado
McQueen, R. B., Geno Rasmussen, C., Waugh, K., Frohnert, B. I., Steck, A. K., Yu, L., Baxter, J., & Rewers, M. (2020) · Diabetes Care · doi:10.2337/dc19-2003 · Cited by 138
Self-citationJacobsen, L. M., Bocchino, L., Evans-Molina, C., DiMeglio, L., Goland, R., Wilson, D. M., Atkinson, M. A., Aye, T., Russell, W. E., Wentworth, J. M., et al. (2020) · Diabetologia · doi:10.1007/s00125-019-05047-w · Cited by 133
“Islet autoantibody testing (starting in 2001) was initially assessed by radioimmunoassay for glutamic acid decarboxylase autoantibodies (GADA), insulin autoantibodies (IAA) and insulinoma-associated antigen-2 autoantibodies (IA-2A) [9].”
MethodKrischer, J. P., Liu, X., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Toppari, J., Ziegler, A.-G., Akolkar, B., & on behalf of the TEDDY Study Group (2017) · Diabetes · doi:10.2337/db17-0261 · Cited by 133
Self-citationHummel, S., Carl, J., Friedl, N., Winkler, C., Kick, K., Stock, J., Reinmüller, F., Ramminger, C., Schmidt, J., Lwowsky, D., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05953-0 · Cited by 129
Self-citationPredicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report
Krischer, J. P., Liu, X., Vehik, K., Akolkar, B., Hagopian, W. A., Rewers, M. J., She, J.-X., Toppari, J., Ziegler, A.-G., Lernmark, Å., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2282 · Cited by 122
Self-citationSousa, G. R., Pober, D., Galderisi, A., Lv, H., Yu, L., Pereira, A. C., Doria, A., Kosiborod, M., & Lipes, M. A. (2019) · Circulation · doi:10.1161/circulationaha.118.036068 · Cited by 117
Self-citationPlasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity
Norris, J. M., Lee, H., Frederiksen, B. N., Erlund, I., Uusitalo, U., Yang, J., Lernmark, Å., Simell, O., Toppari, J., Rewers, M. J., et al. (2017) · Diabetes · doi:10.2337/db17-0802 · Cited by 133
Self-citationTrends in Incidence of Type 1 Diabetes Among Non-Hispanic White Youth in the U.S., 2002–2009
Lawrence, J. M., Imperatore, G., Dabelea, D., Mayer-Davis, E. J., Linder, B., Saydah, S., Klingensmith, G. J., Dolan, L., Standiford, D. A., Pihoker, C., et al. (2014) · Diabetes · doi:10.2337/db13-1891 · Cited by 110
Immune therapy in type 1 diabetes mellitus
Lernmark, Å., & Larsson, H. E. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.237 · Cited by 111
Lampasona, V., Schlosser, M., Mueller, P. W., Williams, A. J., Wenzlau, J. M., Hutton, J. C., Achenbach, P., & Laboratories, P. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.170662 · Cited by 109
Self-citationElding Larsson, H., Vehik, K., Gesualdo, P., Akolkar, B., Hagopian, W., Krischer, J., Lernmark, Å., Rewers, M., Simell, O., She, J.-X., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12066 · Cited by 103
“GADA, IA-2A, and IAA were measured in two laboratories by radio-binding assays (8, 9).”
MethodSelf-citationLampasona, V., Pittman, D. L., Williams, A. J., Achenbach, P., Schlosser, M., Akolkar, B., Winter, W. E., Laboratories, P., Watson, K., Weets, I., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.304196 · Cited by 103
Self-citationReversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study
Vehik, K., Lynch, K. F., Schatz, D. A., Akolkar, B., Hagopian, W., Rewers, M., She, J.-X., Simell, O., Toppari, J., Ziegler, A.-G., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0181 · Cited by 103
Self-citationSerum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes
Zhang, Q., Fillmore, T., Schepmoes, A., Clauss, T. R., Gritsenko, M. A., Mueller, P. W., Rewers, M., Atkinson, M. A., Smith, R. D., & Metz, T. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111843 · Cited by 107
Self-citationSteck, A. K., Dong, F., Geno Rasmussen, C., Bautista, K., Sepulveda, F., Baxter, J., Yu, L., Frohnert, B. I., & Rewers, M. J. (2022) · Diabetes Care · doi:10.2337/dc21-0602 · Cited by 98
Self-citationMiao, D., Guyer, K. M., Dong, F., Jiang, L., Steck, A. K., Rewers, M., Eisenbarth, G. S., & Yu, L. (2013) · Diabetes · doi:10.2337/db13-0534 · Cited by 97
Self-citationPietropaolo, M., Towns, R., & Eisenbarth, G. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012831 · Cited by 95
Self-citationBravis, V., Kaur, A., Walkey, H. C., Godsland, I. F., Misra, S., Bingley, P. J., Williams, A. J. K., Dunger, D. B., Dayan, C. M., Peakman, M., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020904 · Cited by 91
Self-citationVehik, K., Bonifacio, E., Lernmark, Å., Yu, L., Williams, A., Schatz, D., Rewers, M., She, J.-X., Toppari, J., Hagopian, W., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2547 · Cited by 87
Self-citationGubitosi-Klug, R. A., Braffett, B. H., Hitt, S., Arends, V., Uschner, D., Jones, K., Diminick, L., Karger, A. B., Paterson, A. D., Roshandel, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143011 · Cited by 86
Self-citationMichels, A. W., Zhang, L., Khadra, A., Kushner, J. A., REDONDO, M. J., & Pietropaolo, M. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12299 · Cited by 94
Ziegler, A.-G., Pflueger, M., Winkler, C., Achenbach, P., Akolkar, B., Krischer, J. P., & Bonifacio, E. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.02.004 · Cited by 81
Self-citationZhao, S.-X., Tsui, S., Cheung, A., Douglas, R. S., Smith, T. J., & Banga, J. P. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0162 · Cited by 79
Lernmark, Å., & Alshiekh, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.15001-5 · Cited by 79
Krischer, J. P., Liu, X., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Toppari, J., Ziegler, A.-G., Akolkar, B., TEDDY Study Group, et al. (2022) · Diabetes Care · doi:10.2337/dc21-2612 · Cited by 76
Self-citationDabelea, D., Mayer-Davis, E. J., Andrews, J. S., Dolan, L. M., Pihoker, C., Hamman, R. F., Greenbaum, C., Marcovina, S., Fujimoto, W., Linder, B., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2719-6 · Cited by 76
Self-citationWeiss, A., Zapardiel-Gonzalo, J., Voss, F., Jolink, M., Stock, J., Haupt, F., Kick, K., Welzhofer, T., Heublein, A., Winkler, C., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05780-9 · Cited by 74
Self-citationShankar, R. K., Pihoker, C., Dolan, L. M., Standiford, D., Badaru, A., Dabelea, D., Rodriguez, B., Black, M. H., Imperatore, G., Hattersley, A., et al. (2012) · Pediatric Diabetes · doi:10.1111/pedi.12003 · Cited by 76
Prediction and prevention of Type 1 diabetes mellitus
Zhang, L., & Eisenbarth, G. S. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00102.x · Cited by 80
Self-citationAdvances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count
So, M., Speake, C., Steck, A. K., Lundgren, M., Colman, P. G., Palmer, J. P., Herold, K. C., & Greenbaum, C. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab013 · Cited by 80
the Type 1 Diabetes TrialNet Study Group, Bingley, P. J., Boulware, D. C., & Krischer, J. P. (2016) · Diabetologia · doi:10.1007/s00125-015-3830-2 · Cited by 70
Self-citationEarly Infant Diet and Islet Autoimmunity in the TEDDY Study
Uusitalo, U. M., Lee, H., Aronsson, C. A., Vehik, K., Yang, J., Hummel, S., Silvis, K., Lernmark, Å., Rewers, M. J., Hagopian, W., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1983 · Cited by 90
Self-citationUrbina, E. M., Isom, S. P., Bell, R. A., Bowlby, D., D'Agostino, R., Daniels, S. R., Dolan, L. M., Imperatore, G., Marcovina, S. M., Merchant, A. T., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010150 · Cited by 77
Self-citationPugliese, A., Boulware, D., Yu, L., Babu, S., Steck, A. K., Becker, D., Rodriguez, H., DiMeglio, L., Evans-Molina, C., Harrison, L. C., et al. (2016) · Diabetes · doi:10.2337/db15-1105 · Cited by 68
“Laboratory Procedures All autoantibodies were measured using standardized radioimmunoassays (24,25).”
MethodSelf-citationHarmonization of immunoassays for biomarkers in diabetes mellitus
Hörber, S., Achenbach, P., Schleicher, E. D., & Peter, A. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.015 · Cited by 84
Sharma, A. K., Liu, X., Hadley, D., Hagopian, W., Chen, W., Önengüt-Gümüşcü, S., Törn, C., Steck, A. K., Frohnert, B. I., Rewers, M., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.008 · Cited by 76
Self-citationMy Child Is Islet Autoantibody Positive: Impact on Parental Anxiety
Johnson, S. B., Lynch, K. F., Roth, R., Schatz, D., & the TEDDY Study Group (2017) · Diabetes Care · doi:10.2337/dc17-0166 · Cited by 63
Self-citationMarzinotto, I., Pittman, D. L., Williams, A. J. K., Long, A. E., Achenbach, P., Schlosser, M., Akolkar, B., Winter, W. E., Lampasona, V., & laboratories, P. (2023) · Diabetologia · doi:10.1007/s00125-023-05877-9 · Cited by 77
Self-citationLee, H., Burkhardt, B. R., McLeod, W., Smith, S. E., Eberhard, C., Lynch, K. F., Hadley, D., Rewers, M., Simell, O., She, J., et al. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2510 · Cited by 64
Self-citationBosi, E., Boulware, D. C., Becker, D. J., Buckner, J. H., Geyer, S. M., Gottlieb, P. A., Henderson, C., Kinderman, A., Sosenko, J. M., Steck, A. K., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00569 · Cited by 68
Self-citationOral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial
Assfalg, R., Knoop, J., Hoffman, K. L., Pfirrmann, M., Zapardiel‐Gonzalo, J., Hofelich, A., Eugster, A., Weigelt, M., Matzke, C., Reinhardt, J., et al. (2021) · Diabetologia · doi:10.1007/s00125-020-05376-1 · Cited by 71
Self-citationOram, R. A., Sharp, S. A., Pihoker, C., Ferrat, L., Imperatore, G., Williams, A., Redondo, M. J., Wagenknecht, L., Dolan, L. M., Lawrence, J. M., et al. (2022) · Diabetes Care · doi:10.2337/dc20-2872 · Cited by 62
Self-citationAdvances in the Prediction and Natural History of Type 1 Diabetes
Bonifacio, E., & Ziegler, A. G. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.007 · Cited by 61
Self-citationRising incidence of type 1 diabetes is associated with altered immunophenotype at diagnosis
Long, A. E., Gillespie, K. M., Rokni, S., Bingley, P. J., & Williams, A. J. K. (2012) · Diabetes · doi:10.2337/db11-0962 · Cited by 60
“and IA-2A in DK units/mL (14) derived from standard curves, with extrapo-”
MethodSelf-citationLarsson, H. E., Vehik, K., Haller, M. J., Liu, X., Akolkar, B., Hagopian, W., Krischer, J. P., Lernmark, Å., She, J., Simell, O., et al. (2016) · Diabetes · doi:10.2337/db15-1180 · Cited by 67
Self-citationBirth and coming of age of islet autoantibodies
Bonifacio, E. E., & Achenbach, P. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13360 · Cited by 66
Self-citationSauder, K. A., Stafford, J. M., Mayer‐Davis, E. J., Jensen, E. T., Saydah, S., Mottl, A. K., Dolan, L. M., Hamman, R. F., Lawrence, J. M., Pihoker, C., et al. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30309-2 · Cited by 67
Self-citationSteck, A. K., Larsson, H. E., Liu, X., Veijola, R., Toppari, J., Hagopian, W. A., Haller, M. J., Ahmed, S., Akolkar, B., Lernmark, Å., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12485 · Cited by 56
“Autoantibodies to GAD65, IA-2, and ZnT8 were measured in 2 reference laboratories by standard radiobinding assays.(27) For sites in the United States, all serum samples were assayed at the Barbara Davis Center for Childhood Diabetes at the University of Colorado Denver.”
MethodSelf-citationDistinct Growth Phases in Early Life Associated With the Risk of Type 1 Diabetes: The TEDDY Study
Liu, X., Vehik, K., Huang, Y., Larsson, H. E., Toppari, J., Ziegler, A. G., She, J., Rewers, M. J., Hagopian, W., Akolkar, B., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1670 · Cited by 56
Self-citationVehik, K., Fiske, S., Logan, C. A., Agardh, D., Cilio, C., Hagopian, W., Simell, O., Roivainen, M., She, J., Briese, T., et al. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2427 · Cited by 57
Self-citationBonifacio, E., Weiß, A., Winkler, C., Hippich, M., Rewers, M. J., Toppari, J., Lernmark, Å., She, J.-X., Hagopian, W. A., Krischer, J. P., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2122 · Cited by 52
Self-citationElevations in blood glucose before and after the appearance of islet autoantibodies in children
Warncke, K., Weiß, A., Achenbach, P., Berge, T. V. D., Berner, R., Casteels, K., Groele, L., Hatzikotoulas, K., Hommel, A., Kordonouri, O., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci162123 · Cited by 59
Self-citationThe Increasing Onset of Type 1 Diabetes in Children
Hummel, K., McFann, K., Realsen, J., Messer, L. H., KLINGENSMITH, G. J., & Chase, H. P. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.03.061 · Cited by 54
on behalf of the Action LADA consortium, Achenbach, P., Hawa, M. I., Krause, S., Lampasona, V., Jerram, S. T., Williams, A. J. K., Bonifacio, E., Ziegler, A. G., & Leslie, R. D. (2018) · Diabetologia · doi:10.1007/s00125-018-4605-3 · Cited by 51
Self-citationFelton, J. L., REDONDO, M. J., Oram, R. A., Speake, C., Long, S. A., Önengüt-Gümüşcü, S., Rich, S. S., Monaco, G. S. F., Harris-Kawano, A., Perez, D., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00478-y · Cited by 72
Zhao, Z., Miao, D., Michels, A. W., Steck, A. K., Dong, F., Rewers, M., & Yu, L. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.01.011 · Cited by 52
Self-citationGrubb, A. L., McDonald, T. J., Rutters, F., Donnelly, L. A., Hattersley, A. T., Oram, R. A., Palmer, C. N. A., van der Heijden, A. A., Carr, F., Elders, P. J. M., et al. (2019) · Diabetes Care · doi:10.2337/dc18-0431 · Cited by 50
Costs of Public Health Screening of Children for Presymptomatic Type 1 Diabetes in Bavaria, Germany.
Karl, F. M., Winkler, C., Ziegler, A., Laxy, M., & Achenbach, P. (2022) · Diabetes Care · doi:10.2337/dc21-1648 · Cited by 48
Self-citationGalderisi, A., Giannini, C., Weiss, R., Kim, G., Shabanova, V., Santoro, N., Pierpont, B., Savoye, M., & Caprio, S. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30235-9 · Cited by 49
Towns, R., & Pietropaolo, M. (2011) · Drugs of the Future · doi:10.1358/dof.2011.036.11.1710754 · Cited by 88
Challenges in Diagnosing Type 1 Diabetes in Different Populations
Rewers, M. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.2.90 · Cited by 67
3 Screen ELISA for High-Throughput Detection of Beta Cell Autoantibodies in Capillary Blood
Ziegler, A., Haupt, F., Scholz, M., Weininger, K., Wittich, S., Löbner, S., Matzke, C., Gezginci, C., Riethausen, S., Beyerlein, A., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0199 · Cited by 48
Self-citationAmoroso, M., Achenbach, P., Powell, M. J., Coles, R. L., Chlebowska, M., Carr, L., Furmaniak, J., Scholz, M., Bonifacio, E. E., Ziegler, A., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.08.013 · Cited by 58
Self-citationHippich, M., Beyerlein, A., Hagopian, W. A., Krischer, J. P., Vehik, K., Knoop, J., Winker, C., Toppari, J., Lernmark, Å., Rewers, M. J., et al. (2019) · Diabetes · doi:10.2337/db18-0882 · Cited by 47
Self-citationWilliams, A. J. K., Lampasona, V., Schlosser, M., Mueller, P. W., Pittman, D. L., Winter, W. E., Akolkar, B., Wyatt, R., Brigatti, C., Krause, S., et al. (2015) · Diabetes · doi:10.2337/db14-1693 · Cited by 46
Self-citationXu, P., Krischer, J. P., & on behalf of the Type 1 Diabetes TrialNet Study Group (2016) · Diabetes Care · doi:10.2337/dc15-2292 · Cited by 49
Self-citationCortez, F. D. J., Gebhart, D., Robinson, P. V., Seftel, D., Pourmandi, N., Owyoung, J., Bertozzi, C. R., Wilson, D. M., Maahs, D. M., Buckingham, B. A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242049 · Cited by 50
Endesfelder, D., zu Castell, W., Bonifacio, E. E., Rewers, M., Hagopian, W., She, J., Lernmark, Å., Toppari, J., Vehik, K., Williams, A. J. K., et al. (2018) · Diabetes · doi:10.2337/db18-0594 · Cited by 49
Self-citationThe interplay of autoimmunity and insulin resistance in type 1 diabetes.
Nokoff, N., Rewers, M. J., & Cree‐Green, M. (2012) · PubMed · Cited by 51
Metadata
- Authors
- Bonifacio, E., Yu, L., Williams, A. K., Eisenbarth, G. S., Bingley, P. J., Marcovina, S. M., Adler, K., Ziegler, A. G., Mueller, P. W., Schatz, D. A., Krischer, J. P., Steffes, M. W., & Akolkar, B.
- Affiliations
- Center for Regenerative Therapies Dresden (DE)
- University of Colorado Denver (US)
- Clinical Science at North Bristol (A.K.W., P.J.B.), University of Bristol, Southmead Hospital, Bristol BS10 5NB, United Kingdom
- Southmead Hospital (GB)
- University of Washington (US)
- Institute of Diabetes Research (DE)
- Centers for Disease Control and Prevention (US)
- University of Florida (US)
- University of South Florida (US)
- University of Minnesota (US)
- National Institutes of Health (US)
- Corresponding author
- Bonifacio, Ezio
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-07-01
- Volume
- 95
- Issue
- 7
- Pages
- 3360-3367
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2928900
- OpenAlex
- W1965800980
- Semantic Scholar
- c0873ca8aa5d0dfe08d10f351a05ce6e513b77e9
- Cited by
- 291
- References
- 19
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 15 · 2023: 23 · 2022: 25 · 2021: 24 · 2020: 26 · 2019: 22 · 2018: 19 · 2017: 23 · 2016: 20 · 2015: 19 · 2014: 10 · 2013: 18 · 2012: 12
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL61753, R01HL061753, R01HL079611)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-63865, UC4DK063821, DK-63821, P30DK057516, DK 63790, P30 DK 57516, DK63863, DK63861, DK63836, UC4DK063829, U01DK063829, U01DK063790, DK-63829)
- National Center for Research Resources (M01RR000051)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- glutamic acid decarboxylase antibodies, type 1 diabetes, assay concordance, TEDDY study
- MeSH terms
- Academies and Institutes, Adolescent, Adult, Autoantibodies, Glutamate Decarboxylase, Humans, Radioligand Assay, Reference Values, Sensitivity and Specificity, Receptor-Like Protein Tyrosine Phosphatases, Class 8
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.